ClearanceBrief
Recall Z-1459-05 ยท DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

Boston Scientific Corporation

Hemashield Vantage Vascular Graft. Vascular graft prosthesis.

DateSep 28, 2005 (initiated Jun 27, 2005)
StatusTerminated
ReasonDuring surgery, several reports of the grafts fraying and tearing upon suturing by the surgeon.
Root causeOther
ActionRecall notifications were sent out to all customers on 6/27/2005. Enclosed within the recall notification letters are Dear Doctor Letters with directions to the customers to supplyh a copy of it to each physician who has implanted the Hemashield Vantage Vascular Graft.
Quantity3487 devices
DistributionThe devices were distributed to 375 customers in the US, Argentina, Australia, Belgium, China, Colombia, Czech Republic, Germany, Denmark, Spain, France, Great Britain, Italy, Kuwait, Lebanon, Mexico, Malaysia, Netherlands, Norway, New Zealand, Poland, Portugal, Sweden, Singapore and Taiwan.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K961847HEMASHIELD VANTAGE (VASCULAR GRAFT
Meadox Medicals, Div. Boston Scientific Corp., Jan 22, 1997